The latest Fibromyalgia News articles published daily. Includes news on the chronic condition characterized by widespread muscle, tendon and ligament pain, extreme sensitivity to touch and fatigue. The condition is most prevalent amongst women between 35 and 60 years of age although it also affects men and other age groups.
Jazz Pharmaceuticals Announces FDA Acceptance Of Its New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia
20 February 2010
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia...
[
read article]
Jazz Pharmaceuticals Submits New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia
16 December 2009
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for JZP-6 (sodium oxybate oral solution) for the treatment of fibromyalgia...
[
read article]
Urologic And Non-Urologic Unexplained Clinical Conditions Overlap
30 November 2009
UroToday.com - Unexplained clinical conditions have been referred to by many names including functional somatic syndromes. They are characterized by a lack of clear physical or biological etiology, or inconsistent...
[
read article]
For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to: